FDA Recall D-0496-2026
B BRAUN MEDICAL INC · Allentown, PA
Class II Ongoing 42 days on record
Moderate impact — Class II recall — temporary or medically reversible adverse health consequence possible; remote probability of serious adverse health consequence.
Product
DEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B. Braun Medical Inc., Bethlehem, PA 18018-3524, USA, NDC: 0264-7387-50.
Reason for recall
Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.
Recall record
- Recall number
D-0496-2026- Classification
- Class II
- Status
- Ongoing
- Voluntary or mandated
- Voluntary: Firm initiated
- Firm notification
- Letter
- Distribution
- US Nationwide.
- Recall initiated
- 2026-04-02
- Classified by FDA Center
- 2026-04-28
- FDA published
- 2026-04-29
- Recalling firm
- B BRAUN MEDICAL INC
- Firm location
- Allentown, PA
Drug identification
- Brand name(s)
- DEXTROSE
- Generic name(s)
- DEXTROSE
- Manufacturer(s)
- B. Braun Medical Inc.
- NDC(s)
0264-7387- Route(s)
- INTRAVENOUS
Operational response
Class II recalls indicate possible temporary or reversible health consequences. Remove affected lots from active dispensing. Segregate inventory. Check the firm’s recall notification for guidance on patient outreach.
For the official FDA enforcement record, see FDA's Recall Search.